The EU AI Act will enter into force on Thursday, August 1. See timeline and learn more at the link below. Any questions? Reach out to Laura De Boel, Cedric Burton, Yann Padova, or Nikolaos Theodorakis. More information: https://lnkd.in/gJKWND95
About us
Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them. The firm is nationally recognized as a leader in the fields of corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust, among many other areas of law. Our distinguished international roster of clients spans a wide variety of industries, including information technology, life sciences, energy and clean technology, social and traditional media, communications, retail, and financial services. WSGR has offices in Austin; Beijing; Boston; Brussels; Hong Kong; London; Los Angeles; New York; Palo Alto; San Diego; San Francisco; Seattle; Shanghai; Washington, D.C.; and Wilmington, DE. Calling all WSGR alum: Stay connected to alumni, colleagues, and friends on our WSGR Alumni Network, featuring exclusive content and other special offers. Through the site, we share information with alumni about career opportunities; programs and events; alumni, legal industry, and business news; and professional development training, among other topics. Whether you're looking to expand your professional network, find an expert in your field, renew old friendships or establish new ones, or give back by becoming a career mentor, this website is the right place for you. Visit the following link to sign up: www.wsgralumni.com Follow us on Twitter: @wilsonsonsini
- Website
-
http://www.wsgr.com
External link for Wilson Sonsini Goodrich & Rosati
- Industry
- Law Practice
- Company size
- 1,001-5,000 employees
- Headquarters
- Palo Alto, CA
- Type
- Privately Held
- Founded
- 1961
- Specialties
- Law Firm, Corporate Law, Litigation, Intellectual Property, Antitrust, Regulatory, Securities Litigation, Privacy, Class Actions, Investigations, Patent Litigation, Mergers and Acquisitions, Governance, Energy, Tax, Venture Capital, Technology Transactions, and Finance
Locations
-
Primary
650 Page Mill Road
Palo Alto, CA 94304-1050, US
Employees at Wilson Sonsini Goodrich & Rosati
Updates
-
Congratulations to partner Amy Simmerman who was honored as a “Thought Leader” during Corporate Counsel’s 2024 Women, Influence and Power in Law Awards, which honors in-house and law firm women leaders and allies who have demonstrated a commitment to advancing the empowerment of women in law. Learn more about the honorees, who will be recognized at an awards dinner held in Chicago during the Women, Influence & Power in Law Conference in September, at: https://lnkd.in/g9XxWBaP
-
-
#WilsonSonsini Alert: U.S., EU, and UK Competition Authorities Release a Joint Statement Highlighting Competition Risks in Generative AI and Other AI Markets https://bit.ly/3Sqk9jE
-
Our inaugural #WSBioSummit24 will feature a Partnering Hall, which provides personalized opportunities for investors and large pharma companies to meet with #startups that are searching for and pursuing potential investment, partnering, and acquisition opportunities. Learn more at: https://lnkd.in/gy7M9nfW #Biotech
-
-
Recently, partner Dan Ouyang was interviewed by Asian Legal Business (ALB) and discussed her work here at the firm, professional insights for young lawyers, industry updates, and more. Dan's interview was featured in ALB China's July 2024 issue as part of her ALB China Law Awards 2024 - Woman Lawyer of the Year profile. You can read the full article, available in both Chinese and English, at: https://lnkd.in/gGbPf8Fi
-
-
Firm client Dren Bio, Inc., a privately held, clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune, and other serious diseases, announced that it has entered into a strategic collaboration with Novartis Pharma AG! Learn more at: https://lnkd.in/gYKRbhJw
Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer
Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer
businesswire.com
-
Next Tuesday, associate Alicia Umpierre will be at Biocom California's IP & Patent Law Committee Meeting. During the meeting, Alicia will give a presentation on terminal disclaimers, which will cover an introduction of the concept, the recent USPTO proposed rule, and considerations for changes in practice. Learn more at: https://lnkd.in/gueMEp9t
Biocom California IP Committee Meeting
wsgr.com
-
Next month, we're hosting the 7th session in our Digital Health Webinar Series which will discuss significant new #AI and privacy developments happening in 2024 that will impact #digitalhealth companies. Learn more and register for the event, which will include insights from Tracy Shapiro, Maneesha Mithal, Hale Melnick, and Andrea Linna, at: https://lnkd.in/gShwrCNi
-
-
In May, France adopted law No. 2024-449 to secure and regulate the digital space. This law grants new enforcement powers and authority to the French Data Protection Authority, including to seize documents, record declarations during dawn raids, and enforce certain provisions of the Digital Services Act and the Digital Governance Act. Learn more from our Data Advisor authors Yann Padova & Marie Catherine Ducharme: https://lnkd.in/getdBMbu
New Enforcement Powers for the French Data Protection Authority (CNIL) | The Data Advisor
https://www.wsgrdataadvisor.com